Verition Fund Management
VIR icon

Verition Fund Management’s Vir Biotechnology VIR Stock Holding History

Verition Fund Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-59,670
Closed -$301K – 4010
2025
Q2 		$301K Buy
+59,670
New +$320K ﹤0.01% 3201
2025
Q1 		– Sell
-145,873
Closed -$1.07M – 3744
2024
Q4 		$1.07M Buy
145,873
+93,079
+176% +$734K ﹤0.01% 2000
2024
Q3 		$395K Buy
+52,794
New +$459K ﹤0.01% 2465
2024
Q2 		– Sell
-11,714
Closed -$119K – 3278
2024
Q1 		$119K Buy
+11,714
New +$119K ﹤0.01% 2564
2022
Q4 		– Sell
-16,646
Closed -$321K – 2776
2022
Q3 		$321K Buy
+16,646
New +$423K ﹤0.01% 2176
2022
Q2 		– Sell
-14,090
Closed -$362K – 3086
2022
Q1 		$362K Buy
14,090
+5,901
+72% +$175K ﹤0.01% 2073
2021
Q4 		$343K Buy
+8,189
New +$321K ﹤0.01% 1919
2020
Q3 		– Sell
-40,536
Closed -$1.66M – 1388
2020
Q2 		$1.66M Buy
+40,536
New +$1.36M 0.05% 269

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return